Strongyloides Stercoralis Public Health Control in Rwanda
NCT ID: NCT07009613
Last Updated: 2025-06-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1415 participants
OBSERVATIONAL
2024-09-23
2024-10-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Strongyloidiasis at CHRU Nancy: Evaluation of the Performance of Serological Tests and Disease-associated Characteristics
NCT07296198
Development of a New Rapid Diagnostic Test to Support Onchocerciasis Elimination
NCT06350851
Women and Children as the Focus for Control of Schistosomiasis Infections in the Irrigations Area of Burkina Faso
NCT00463528
Management of Soil-transmitted Helminthiasis and Strongyloidiasis
NCT01308268
Safety and Efficacy of Drug Combinations Against Schistosomiasis
NCT01050374
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Parasitological tests
The primary outcome was reported based on the technicians' answers collected with a structured questionnaire. The individuals screened underwent testing with the tests detailed above
Questionnaire
The primary outcome was based on the technicians' evaluation, based on their answers collected in a questionnaire. The individuals screened were tested with assays used for the national control programmes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Obtainment of written informed consent (for children's participation, consent was sought from parents/guardians).
Exclusion Criteria
5 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Rwanda
OTHER
Rwanda Biomedical Centre
OTHER
IRCCS Sacro Cuore Don Calabria di Negrar
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dora Buonfrate
Head of infectious disease Clinical Research Unit
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
School of Health Sciences, College of Medicine and Health Sciences, University of Rwanda
Kigali, , Rwanda
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
No477/RNEC/2024
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.